ロード中...
Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?
An individual’s inherited genetic makeup and acquired genomic variants may account for a significant portion of observable variability in therapy efficacy and toxicity. Pharmacogenomics (PGx) is the concept that treatments can be modified to account for these differences to increase chances of thera...
保存先:
| 出版年: | Hum Mol Genet |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7574955/ https://ncbi.nlm.nih.gov/pubmed/32601683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddaa134 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|